Pemoline Information

   Since before receiving FDA approval in 1975, Pemoline® has
been linked to 21 cases of liver failure, 13 of which have resulted in
liver replacement or death.

    Recently the Public Citizen has issued a petition to the FDA
asking for the drug to be removed from the market. "The Food and
Drug Administration should immediately ban the sale of
Pemoline®," said Dr. Sidney Wolfe, director of Public Citizen's
Health Research Group. "Relatively safe and effective drug
treatments exist for ADHD, and since there are no data that
demonstrate Pemoline® has any unique benefit over other drugs,
there is no responsible basis for keeping this unacceptably
dangerous drug on the market."

    Pemoline®, which also goes by the generic name Cylert, is a
central nervous system stimulant used in the treatment of attention
deficit hyperactivity disorder (ADHD).